Gelatin Capsule Market Size, Share, Growth, and Industry Analysis, By Types (Soft Gelatin Capsule, Hard Gelatin Capsule) , Applications (Preparation of Drugs, Preparation of Health Care Products) and Regional Insights and Forecast to 2035

Gelatin Capsule Market Size

The Gelatin Capsule Market is projected to grow from USD 3.18 billion in 2025 to USD 3.41 billion in 2026, reaching USD 3.64 billion in 2027 and expanding to USD 6.26 billion by 2035, registering a CAGR of 7.01% during 2026–2035. Pharmaceutical applications account for nearly 55%, dietary supplements exceed 35%, hard capsules represent 60%, and Asia-Pacific holds approximately 48% market share. Growth is driven by nutraceutical demand, pharmaceutical expansion, and preference for easy-to-consume dosage forms.

The US Gelatin Capsule market is experiencing steady growth, driven by rising consumer preference for plant-based and halal-certified capsules, as well as advancements in drug delivery systems.

The gelatin capsule market is experiencing robust growth due to the rising adoption of oral drug delivery systems in pharmaceuticals and nutraceuticals. More than 65% of prescription drugs are now available in capsule form, with gelatin capsules accounting for over 80% of the market share.

The increasing demand for functional foods and dietary supplements, particularly in sports nutrition, immunity boosting, and weight management, is further propelling the industry. More than 50% of consumers prefer capsules over tablets due to their faster dissolution rates and ease of swallowing. The demand for vegetarian and halal-certified gelatin capsules is also rising, with over 40% of manufacturers now offering plant-based alternatives.

Gelatin Capsule Market Trends

The gelatin capsule market is evolving rapidly, driven by technological advancements and consumer preference shifts. Soft gelatin capsules (softgels) dominate the market, accounting for over 70% of the total capsule consumption due to their enhanced bioavailability and superior absorption rates. The demand for plant-based capsules is growing, with HPMC capsules witnessing a market growth of over 35% year-over-year.

The pharmaceutical industry contributes more than 60% to the gelatin capsule demand, especially in oncology, cardiovascular diseases, and pain management treatments. Additionally, over 55% of newly launched drugs are encapsulated in gelatin-based formats, reflecting industry preference for high stability and controlled-release mechanisms.

Regionally, Asia-Pacific holds over 45% of the global gelatin capsule market, fueled by the expanding pharmaceutical industry in China and India. Meanwhile, North America and Europe contribute over 40% to the market, driven by advanced drug delivery innovations and regulatory approvals. The nutraceutical sector accounts for nearly 30% of gelatin capsule applications, driven by rising consumer awareness about preventive healthcare and dietary supplements.

Gelatin Capsule Market Dynamics

DRIVER

"Increasing Demand for Pharmaceuticals"

The pharmaceutical sector accounts for more than 60% of gelatin capsule usage, with over 75% of newly developed drugs requiring capsule-based formulations for enhanced stability and bioavailability. The global aging population, expected to rise by more than 50% by 2050, is further accelerating demand for easy-to-swallow dosage forms. Additionally, over 70% of patients prefer gelatin capsules due to their fast disintegration and improved taste masking, making them a preferred choice for chronic disease treatments.

RESTRAINT

"Ethical and Religious Concerns"

Despite their advantages, over 30% of consumers globally avoid animal-derived gelatin capsules due to religious and dietary restrictions. As a result, vegetarian and vegan capsules are witnessing a demand surge of over 40% annually. However, plant-based capsules are up to 25% more expensive to produce than traditional gelatin capsules, creating cost challenges for manufacturers. Additionally, over 20% of gelatin raw material supplies face fluctuations due to livestock industry trends and environmental concerns.

OPPORTUNITY

"Rising Demand for Personalized Medicine"

The demand for personalized medicine is surging, with over 50% of pharmaceutical companies investing in custom capsule formulations. More than 45% of new drug approvals feature controlled-release gelatin capsules, ensuring precise drug delivery. Furthermore, more than 30% of nutraceutical brands are now offering tailored capsule solutions, including multi-layered capsules, enteric-coated options, and liquid-filled softgels, catering to individual health needs.

CHALLENGE

"Rising Costs and Compliance Regulations"

The production cost of gelatin capsules has increased by over 20% in the past five years, driven by regulatory compliance and rising raw material prices. Strict FDA, EMA, and WHO guidelines require over 90% of capsule manufacturers to comply with Good Manufacturing Practices (GMP), adding significant operational expenses. Additionally, over 35% of manufacturers report challenges in sourcing sustainable gelatin, further impacting supply chain stability.

Segmentation Analysis

The gelatin capsule market is categorized based on type and application, with each segment playing a crucial role in market expansion. Soft gelatin capsules (softgels) dominate the market, holding over 70% of the total capsule consumption, primarily due to their superior bioavailability and ease of swallowing. Meanwhile, hard gelatin capsules account for over 25% of the market share, preferred in solid dosage formulations for pharmaceutical drugs. By application, the pharmaceutical sector represents more than 60% of total gelatin capsule usage, while the healthcare and nutraceuticals segment contributes over 30%, driven by rising demand for dietary supplements and functional foods.

By Type

• Soft Gelatin Capsules (Softgels): Soft gelatin capsules dominate the global market, accounting for over 70% of total consumption. These capsules are widely used due to their higher absorption rates, tamper resistance, and improved bioavailability. More than 65% of over-the-counter (OTC) medications, including pain relievers, vitamins, and dietary supplements, are available in softgel forms. Softgels are also witnessing strong demand in the cosmeceuticals industry, with over 30% of skincare and beauty supplements utilizing soft gelatin formulations. Their liquid encapsulation allows for better dosage control, making them a preferred choice in the pharmaceutical and nutraceutical industries.
• Hard Gelatin Capsules: Hard gelatin capsules hold over 25% of the total gelatin capsule market, mainly used for solid drugs, powders, and granulated formulations. These capsules are particularly popular in prescription and OTC medications, accounting for over 60% of encapsulated solid drugs. They offer better stability and controlled-release formulations, making them suitable for antibiotics, probiotics, and anti-inflammatory drugs. In addition, over 40% of nutraceutical products, including herbal supplements and protein powders, are now packaged in hard gelatin capsules due to their cost-effectiveness and ease of mass production.

By Application

• Preparation of Drugs: The pharmaceutical industry dominates the gelatin capsule market, accounting for over 60% of total applications. Capsules are used for prescription drugs, controlled-release medications, and specialty drugs, with over 55% of newly developed medications adopting gelatin-based encapsulation. More than 80% of pain management drugs use gelatin capsules due to their fast dissolution properties, ensuring rapid relief. Additionally, the oncology sector represents more than 25% of total gelatin capsule usage, as capsule-based formulations are preferred for targeted drug delivery in cancer treatments.
• Preparation of Health Care Products: The healthcare and nutraceutical industry represents over 30% of gelatin capsule applications, driven by the growing demand for dietary supplements. More than 50% of global vitamin and mineral supplements are now encapsulated in gelatin capsules, ensuring better stability and higher absorption rates. The rising preference for plant-based and organic supplements has led to a 40% surge in demand for vegetarian gelatin capsules. Additionally, over 35% of sports nutrition supplements utilize gelatin capsules for encapsulated protein powders, omega-3 supplements, and energy boosters.

Gelatin Capsule Regional Outlook

The gelatin capsule market exhibits strong regional diversification, with Asia-Pacific, North America, and Europe collectively contributing over 80% of the global market. While North America and Europe lead in technological innovations and regulatory advancements, Asia-Pacific dominates production and consumption due to lower manufacturing costs and an expanding pharmaceutical sector. The Middle East & Africa market is witnessing steady growth, driven by the increasing adoption of dietary supplements and pharmaceutical advancements.

North America

North America holds over 35% of the global gelatin capsule market, with the United States accounting for more than 80% of regional demand. Over 70% of prescription and OTC drugs in the region are encapsulated in gelatin-based forms, supporting strong market expansion. Additionally, the rising demand for dietary supplements, with over 60% of U.S. adults consuming at least one supplement daily, is fueling gelatin capsule consumption. More than 50% of capsule manufacturers in North America focus on high-tech, controlled-release formulations, ensuring sustained industry growth.

Europe

Europe contributes over 25% to the global gelatin capsule market, with Germany, France, and the UK accounting for more than 70% of regional sales. The pharmaceutical sector remains the largest consumer of gelatin capsules, representing over 65% of the European market. Additionally, over 40% of European consumers prefer vegan and vegetarian supplements, leading to a 35% surge in demand for plant-based gelatin alternatives. The region is also a hub for pharmaceutical innovations, with more than 45% of new capsule-based drug formulations originating from European R&D facilities.

Asia-Pacific

The Asia-Pacific region dominates the global gelatin capsule market, accounting for over 45% of total consumption. China and India contribute more than 70% of regional production, fueled by low manufacturing costs and expanding pharmaceutical industries. The demand for pharmaceutical capsules is growing by over 30% annually, driven by increased chronic disease cases and aging populations. In addition, the nutraceutical industry in the region has seen a 50% surge in demand for gelatin-based dietary supplements, with Japan and South Korea leading in functional food innovations.

Middle East & Africa

The Middle East & Africa market accounts for over 5% of global gelatin capsule sales, with a 20% annual increase in pharmaceutical capsule consumption. The rising prevalence of chronic diseases, particularly in GCC countries and South Africa, is driving demand for prescription drug capsules. Additionally, over 30% of the population in the region consumes dietary supplements, fueling growth in the nutraceutical sector. Halal-certified gelatin capsules are witnessing a demand surge of over 40% annually, making them a preferred choice in Muslim-majority markets such as Saudi Arabia, UAE, and Indonesia.

List of Key Gelatin Capsule Market Companies Profiled

• Roxlor
• ERAWAT PHARMA LIMITED
• Kangke
• Suheung
• Lefan Capsule
• MEIHUA Group
• Dah Feng Capsule
• Farmacapsulas SA
• Capsugel
• Nectar Lifesciences Ltd.
• Yili Capsule
• ACG ACPL
• Shing Lih Fang
• Qualicaps
• Angtai
• Qinhai Gelatin Company
• Huangshan Capsule

Top Companies with the Highest Market Share

• Capsugel – Holds over 30% of the global gelatin capsule market share, recognized as the leading supplier for pharmaceutical and nutraceutical applications. The company’s extensive R&D investments and advanced encapsulation technologies position it at the forefront of the industry.

• ACG ACPL – Accounts for over 20% of the global gelatin capsule market, with a strong presence in Asia-Pacific and Europe. The company is a leading provider of customized capsule solutions, catering to pharmaceutical, nutraceutical, and functional food industries.

Investment Analysis and Opportunities

The gelatin capsule market has seen a surge in investments, with over 40% of pharmaceutical and nutraceutical manufacturers increasing their budgets for advanced capsule production. Major investors are focusing on plant-based and functional gelatin capsules, with more than 35% of new investments directed toward hydroxypropyl methylcellulose (HPMC) capsules. Additionally, the rise of biopharmaceuticals has led to a 50% increase in funding for controlled-release and targeted drug delivery capsules.

The Asia-Pacific region attracts over 45% of global investments in gelatin capsule production, with China and India leading in cost-efficient manufacturing. In contrast, North America and Europe receive over 30% of total investments, primarily in R&D for sustainable and biodegradable capsule solutions. More than 60% of new pharmaceutical projects in these regions now include capsule-based formulations.

In the nutraceutical segment, over 55% of supplement manufacturers are investing in softgel capsules, targeting sports nutrition and immunity-boosting products. The halal and kosher-certified gelatin capsule market is also growing, with over 25% of new investments focusing on religious-compliant capsules to cater to expanding consumer bases in the Middle East, Southeast Asia, and North Africa.

New Product Development

The gelatin capsule industry has witnessed a significant rise in new product launches, with over 50% of pharmaceutical companies introducing modified-release and enteric-coated gelatin capsules for precision drug delivery. In 2023 and 2024, more than 30% of new capsule formulations featured dual-layer or multi-phase release technology, ensuring better drug absorption and reduced side effects.

The demand for vegan and plant-based gelatin alternatives has grown, leading to a 40% increase in HPMC capsule production. Additionally, over 20% of supplement manufacturers have launched marine-based gelatin capsules, catering to the rising demand for sustainable and allergen-free supplements.

Softgel capsules remain dominant, with more than 60% of new dietary supplements adopting soft gelatin encapsulation due to enhanced bioavailability. The functional food industry has also seen a 35% rise in the development of fortified gelatin capsules, offering omega-3, CBD, and vitamin-enriched formulations.

In the pharmaceutical sector, over 45% of drug manufacturers have developed personalized medicine capsules, with a focus on oncology, neurology, and cardiology treatments. Additionally, liquid-filled and microencapsulated softgels are emerging as a new trend, accounting for 30% of new softgel developments in the past two years.

Recent Developments by Manufacturers in 2023 and 2024

1. In 2023, Capsugel (Lonza) launched next-generation plant-based capsules, increasing production capacity by over 35% to meet rising demand for vegan alternatives.

2. ACG Capsules announced a 30% expansion in its gelatin capsule production facilities in 2023, with a focus on sustainable and biodegradable gelatin materials.

3. In early 2024, Suheung introduced gelatin capsules infused with probiotics, enhancing gut health benefits and capturing more than 20% of the functional capsule market.

4. Farmacapsulas SA increased its production capacity by 25% in 2023, targeting the North American and European markets for enteric-coated gelatin capsules.

5. In Q1 2024, MEIHUA Group launched a new line of halal and kosher-certified gelatin capsules, seeing a 40% increase in demand from Middle Eastern and Southeast Asian markets.

6. Qualicaps introduced a range of micro-encapsulated liquid softgels in 2023, with a 30% rise in demand for omega-3 and vitamin-infused capsules.

7. Nectar Lifesciences Ltd. announced a partnership with nutraceutical brands in 2024, enabling a 50% increase in production of dietary supplement capsules.

Report Coverage of Gelatin Capsule Market

The gelatin capsule market report provides a detailed analysis of industry trends, market segmentation, investment opportunities, and technological advancements. Covering over 20 key manufacturers, the report examines market size, competitive landscape, and emerging product innovations.

• Market Segmentation: Includes detailed breakdown by type (softgel, hard gelatin) and application (pharmaceutical, nutraceutical, functional food, and personal care).
• Regional Insights: Analyzes North America, Europe, Asia-Pacific, and Middle East & Africa, highlighting market share, production trends, and consumer preferences.
• Investment Trends: Tracks new funding, R&D initiatives, and expansion strategies, with a focus on plant-based and controlled-release capsules.
• Technological Developments: Covers biodegradable capsules, nanoencapsulation, and multi-phase release technologies, which have seen a 40% rise in adoption over the past two years.
• Competitive Landscape: Examines key industry players, their market shares, recent product launches, and strategic collaborations.

Additionally, the report provides insights into regulatory frameworks, consumer preferences, and sustainability initiatives, ensuring a comprehensive market assessment for stakeholders and investors.